Measuring the success of blinding in placebo-controlled trials: Should we be so quick to dismiss it?

Measuring the success of blinding in placebo-controlled trials: Should we be so quick to dismiss it?

‘Blinding’ involves concealing knowledge of which trial participants received the interventions from participants themselves and other trial personnel throughout the trial. Blinding reduces bias arising from the beliefs and expectations of these groups. It is agreed that where possible, blinding sho...

Full description

Saved in:
Bibliographic Details
Main Authors: Rebecca K Webster, Felicity Bishop, Gary S Collins, Andrea WM Evers, Tammy Hoffmann, J André Knottnerus, Sarah E Lamb, Helen Macdonald, Claire Madigan, Vitaly Napadow, Amy Price, Jonathan L Rees, Jeremy Howick
Format: Default Article
Published: 2021
Subjects:
Blinding
Masking
Trials
Measuring
Reporting guidelines
Science & Technology
Life Sciences & Biomedicine
Health Care Sciences & Services
Public, Environmental & Occupational Health
RANDOMIZED CLINICAL-TRIALS
OBSERVER BIAS
COMMON COLD
BLINDNESS
OUTCOMES
Epidemiology
Mathematical Sciences
Medical and Health Sciences
Online Access:https://hdl.handle.net/2134/16810066.v1
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://hdl.handle.net/2134/16810066.v1

Similar Items